Ambalal Sarabhai Enterprises Ltd Share Price Today - Ambalal Sarabhai Enterprises Ltd Stock Price Live NSE/BSE

Ambalal Sarabhai Enterprises Ltd

NSE: AMBASARABH BSE: 500009

₹33.17

(4.60%)

Sun, 17 May 2026, 09:40 pm

MTF 5xInvest in Ambalal Sarabhai Enterprises Ltd with 5x Leverage Buy with MTF

Market Cap2.54B

PE Ratio23.04

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Ambalal Sarabhai Enterprises Share Price Live Chart

1 Day

(4.60%)

No Result Found

Summary

Market Cap
247.83
Net Profit
4.93
P/B
1.92
Sector P/E
35.36
P/E
54.77
EV/EBITDA
22.60
Debt/Equity (Industry)
0.52
Interest Cover (Industry)
0
ROCE (Industry)
0
RONW (Industry)
0
ROE
6.05
ROCE
8.87
Debt/Equity
0.35
EPS (TTM)
2.31
Dividend Yield
0
Book Value
19.25
Interest Cover
3.55

Analysis

all

Pros

Ambalal Sarabhai Enterprises is profitable, therefore cash runway is not a concern.
Ambalal Sarabhai Enterprises is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 2.1x debt.
Ambalal Sarabhai Enterprises's cash and other short term assets cover its long term commitments.
Ambalal Sarabhai Enterprises had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.

Cons

Unable to evaluate Ambalal Sarabhai Enterprises's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Ambalal Sarabhai Enterprises's dividend against the top 25% market benchmark as the company has not reported any payouts.
Ambalal Sarabhai Enterprises's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
Debt is not well covered by operating cash flow (7.1%, less than 20% of total debt).
Ambalal Sarabhai Enterprises's level of debt (179.9%) compared to net worth is high (greater than 40%).

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	31.36	31.36	31.35	31.35	31.35
FII	0	0.34	0.34	0.38	0.38
DII	0.01	0.01	0.01	0.01	0.10
Public	68.64	68.29	68.31	68.27	68.17
Government	0	0	0	0	0

Technical Analysis

RSI

55.33

MACD

0.64

50 DMA

28.98

200 DMA

29.94

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	54.52	42.57	37.18	30.62	25.23	18.67	6.72
Fibonacci	42.57	38.00	35.18	30.62	26.05	23.23	18.67
Camarilla	35.09	33.99	32.90	30.62	30.70	29.61	28.51

Pivots Level: Classic

+23.90

54.52

+11.95

42.57

+6.57

37.18

30.62

Pivot Point

LTP: 32.20

-5.38

25.23

-11.95

18.67

-23.90

6.72

Moving Average

SMAEMA

Period

Value

10-EMA
31.70
20-EMA
31.39
30-EMA
30.82
50-EMA
29.94
100-EMA
29.41
200-EMA
31.16

Announcement Date	Purpose	Action
12 Feb 2026	board-meetings	Quarterly Results
30 May 2025	agm
24 May 2024	agm
24 Aug 2023	agm
17 Aug 2023	egm
10 Aug 2022	agm
11 Aug 2021	agm

Ambalal Sarabhai Enterprises Ltd

Divis Laboratories Ltd

Cipla Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Ambalal Sarabhai Enterprises Ltd About

Ambalal Sarabhai Enterprises is engaged in manufacturing Pharmaceuticals.

Industry

Trading

Founded

1977

Headquarters

CEO

Kartikeya V Sarabhai

Employees

Contact

Website

http://www.ase.life

ase@sarabhai.co.in

Phone

91-79-25507671/25507073

Location

Shanti Sadan, Mirzapur Road, Ahmedabad, Gujarat, 380001

Year	History
2007	Ambalal Sarabhai Enterprises Ltd appointed Mr. B S Bohra as Additional Director of the Company.
2008	The Company acquired 100% paid-up share capital of Suvik Hi-tek Pvt. Ltd., making it a wholly owned subsidiary.
2012	Ms. Chaula Shastri joined the Board of Directors as a Whole-Time Director of the Company.
2016	The Company changed its registered office address from Sarabhai Campus Gorwa Road, Vadodara to Shanti Sadan Mirzapur Road, Ahmedabad.
2023	The Company launched new products 'Rapid Daignostics Product Range' A.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
MONET SECURITIES PRIVATE LTD	bulk	Sell	821593	34.57	18 Jun 2021
ALPHA LEON ENTERPRISES LLP	bulk	Buy	447507	34.15	18 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITED	bulk	Buy	396891	34.82	18 Jun 2021
ALPHA LEON ENTERPRISES LLP	bulk	Sell	447507	35.73	18 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITED	bulk	Sell	847922	34.91	18 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITED	bulk	Buy	1915316	46.21	10 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITED	bulk	Sell	838822	47.36	10 Jun 2021
TEJAS TRADEFIN LLP	bulk	Buy	410294	46.67	10 Jun 2021
MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED	bulk	Buy	876252	46.74	10 Jun 2021
TEJAS TRADEFIN LLP	bulk	Sell	308594	47.53	10 Jun 2021

Ambalal Sarabhai Enterprises Ltd News

Ambalal Sarabhai Board Meet Set for May 21, 2026

Ambalal Sarabhai Enterprises schedules Board Meeting on May 21, 2026 to approve audited financial results for Q4 and FY26, and fix AGM date.

14 May 2026

companies

Ambalal Sarabhai Submits SEBI Compliance Certificate

Ambalal Sarabhai Enterprises Limited filed mandatory certificate under SEBI Regulation 74(5) for period ended March 31, 2026, confirming proper dematerialization processes.

09 Apr 2026

companies

Ambalal Sarabhai Enterprises Reports Mixed Q2 Performance with Consolidated Loss Despite Revenue Growth

Ambalal Sarabhai Enterprises Limited reported consolidated revenue from operations of Rs 4,444.92 lakhs for the quarter ended September 30, 2025, compared to Rs 4,470.61 lakhs in the same period last year. The company posted a consolidated net loss of Rs 36.03 lakhs for the quarter versus a profit of Rs 261.99 lakhs in the previous year. For the half-year period, consolidated revenue reached Rs 8,478.80 lakhs with net profit of Rs 766.32 lakhs. On a standalone basis, the company recorded a loss of Rs 38.24 lakhs for the quarter. The company operates in two business segments - Pharmaceuticals and Electronics. Basic earnings per share stood at negative Rs 0.07 for the quarter. The Board of Directors approved these unaudited financial results in their meeting held on November 12, 2025.

12 Nov 2025

earnings

Ambalal Sarabhai Enterprises' Joint Venture CoSara Diagnostics Explores SPAC Transaction

Ambalal Sarabhai Enterprises Limited announced that Co-Diagnostics Inc., its joint venture partner in CoSara Diagnostics Pvt. Ltd., has engaged Maxim Group LLC as exclusive financial advisor to explore strategic alternatives for the Indian joint venture. The options include a potential merger with a Special Purpose Acquisition Company (SPAC) or similar entity listed on a U.S. national securities exchange. CoSara Diagnostics, established in 2017, is a joint venture between Co-Diagnostics Inc. and Synbiotics Ltd., with the latter being a group company of Asence Inc., both subsidiaries of Ambalal Sarabhai Enterprises. The joint venture focuses on manufacturing and selling molecular diagnostics products to patients and healthcare providers in international markets, with initial focus on India. Co-Diagnostics CEO Dwight Egan stated the company aims to unlock value for CoSara and shareholders while helping the venture realize its founding vision.

06 Nov 2025

order&deals

Ambalal Sarabhai's Telerad Division Wins Best Regional Distributor Award at Broadcast India Show 2025

Ambalal Sarabhai Enterprises Limited announced that its Telerad division, which operates under Systronics India Limited, received the 'Best Regional Distributor — Broadcast - West Award' at the Broadcast India Show 2025 held in Mumbai in October 2025. Telerad is described as a total solution company and leading system integrator that provides complete end-to-end solutions in broadcast segments. The award recognizes Telerad's leadership in delivering innovative broadcast solutions and exceptional services to industries.

27 Oct 2025

stock

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800